SINOVAC BIOTECH LTD
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2009 | $48.4M | $44.1M | $4.3M | $422.9K |
| FY2010 | $-14.3M | $-39.1M | $24.8M | $459.9K |
| FY2011 | $13.9M | $-1.5M | $15.5M | $206.0K |
| FY2012 | $-16.3M | $-32.4M | $16.2M | $347.0K |
| FY2013 | $5.6M | $443.0K | $5.1M | $281.0K |
| FY2014 | $-10.1M | $-21.0M | $10.9M | $287.0K |
| FY2015 | $4.2M | $-1.1M | $5.3M | $952.0K |
| FY2016 | $-13.9M | $-26.6M | $12.7M | $2.4M |
| FY2017 | $59.8M | $47.8M | $11.9M | $979.0K |
| FY2018 | $7.9M | $2.3M | $5.6M | $4.3M |
| FY2019 | $39.1M | $28.4M | $10.6M | $3.0M |
| FY2020 | $479.3M | $351.8M | $127.5M | $10.2M |
| FY2021 | $15.32B | $14.73B | $594.2M | $7.7M |
| FY2022 | $-798.1M | $-1.11B | $313.9M | $0 |
| FY2023 | $138.6M | $-17.5M | $156.2M | $0 |
| FY2024 | $-56.9M | $-152.9M | $96.0M | $0 |
| FY2025 | $-512.2M | $-561.1M | $48.9M | — |